53 State Street 40th Floor,
Boston, Massachusetts 02109
United States
(617) 918-4000
www.leerink.com
Leerink Partners is an investment bank specializing in the healthcare sector. Firm services include capital markets access, M&A advisory, and research. Leerink Swann LLC has offices in Boston, New York City, and San Francisco.
Year | ≤ '19 | '20 | '21 | '22 | '23 | '24 | T |
---|---|---|---|---|---|---|---|
Buyside (1.2/yr) | 10 | 2 | 2 | - | - | 2 | 16 |
Sellside (1.8/yr) | 19 | 3 | 2 | - | 3 | 1 | 28 |
44 |
Target Company | Date | Value | Type |
---|---|---|---|
Sign-up to View | 2024-09-12 | - | Internet Software and Services |
Sign-up to View | 2024-04-11 | - | Life Science |
Sign-up to View | 2024-01-30 | - | Life Science |
Sign-up to View | 2023-12-22 | - | Life Science |
Sign-up to View | 2023-09-27 | - | Life Science |
Sign-up to View | 2023-08-09 | 109M USD | Life Science |
Sign-up to View | 2021-07-29 | - | Business Services |
Sign-up to View | 2021-06-25 | 820M USD | Healthcare Services |
Sign-up to View | 2021-05-04 | 185M USD | Life Science |
Sign-up to View | 2021-03-09 | 164M USD | Life Science |
View All >> |
Sector | # | Value | |
---|---|---|---|
Life Science | Sign-up to View | ||
Medical Products | Sign-up to View | ||
Healthcare Services | Sign-up to View | ||
Information Technology | Sign-up to View | ||
Internet Software and Services | Sign-up to View | ||
Business Services | Sign-up to View | ||
Total | Sign-up to View |
State/Country | # | Value | |
---|---|---|---|
United States | Sign-up to View | ||
Massachusetts | Sign-up to View | ||
California | Sign-up to View | ||
New Jersey | Sign-up to View | ||
North Carolina | Sign-up to View | ||
Texas | Sign-up to View | ||
Montana | Sign-up to View | ||
Washington | Sign-up to View | ||
Maryland | Sign-up to View | ||
Kentucky | Sign-up to View | ||
Florida | Sign-up to View | ||
United Kingdom | Sign-up to View | ||
Domestic | Sign-up to View | ||
Cross-border | Sign-up to View | ||
Total | Sign-up to View |
Type | # | Value | |
---|---|---|---|
Add-on Acquisition | Sign-up to View | ||
Merger | Sign-up to View | ||
Divestiture | Sign-up to View | ||
Recapitalization | Sign-up to View | ||
Secondary Buyout | Sign-up to View | ||
Growth Capital | Sign-up to View | ||
Joint Venture | Sign-up to View | ||
Total | Sign-up to View |
PE Firms (2) | Deals |
---|---|
Sign-up to View |
1 |
Sign-up to View |
1 |
Corporate (41) | Deals |
---|---|
Sign-up to View |
2 |
Sign-up to View |
1 |
Sign-up to View |
1 |
Value | # | TOTAL |
---|---|---|
> $1B | Sign-up to View | |
$100M to $1B | Sign-up to View | |
< $100M | Sign-up to View | |
TOTAL | Sign-up to View | |
Largest |
NPS Pharmaceuticals, Inc. $5.2B (2015-02-21) |